Arie Belldegrun

13F Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 12.7M shares
Security Ownership: 5.6%

Arie Belldegrun, M.D. ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)

2025-11-13 - Arie Belldegrun, M.D. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12.7M shares of Allogene Therapeutics, Inc. Common Stock (ALLO). This represents 5.6% percent ownership of the company. In their previous filing dated 2025-08-12, Belldegrun Arie had reported owning 12.6M shares, indicating an increase of 0.5% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Arie Belldegrun, M.D.	5.6%	-1.67%	$15.7M	12.7M	+62,450	+0.5%	$1.24	13G/A	9/30/2025	13 Nov 2025 19:09:38
Arie Belldegrun, M.D.	5.7%		$14.2M	12.6M	+62,450	+0.5%	$1.13	13G/A	6/30/2025	12 Aug 2025 16:57:37
Arie Belldegrun, M.D.	5.7%	-1.67%	$17.2M	12.5M	+149,877	+1.21%	$1.37	13G/A	3/31/2025	9 May 2025 17:30:51
Arie Belldegrun, M.D.	5.8%		$17M	12.4M			$1.37	13G/A	12/31/2024	13 Feb 2025 16:31:35